Global Orexin Receptor Antagonists for Insomnia Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Orexin Receptor Antagonists for Insomnia market size is projected to grow from US$ 1076.1 million in 2022 to US$ 3354.3 million in 2029; it is expected to grow at a CAGR of 17.6% from 2023 to 2029.
United States market for Orexin Receptor Antagonists for Insomnia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Orexin Receptor Antagonists for Insomnia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Orexin Receptor Antagonists for Insomnia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Orexin Receptor Antagonists for Insomnia players cover MSD, Eisai Co., Ltd. and Idorsia, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Suvoresan is believed to play a therapeutic role in the treatment of insomnia by blocking orexin receptors and inhibiting the effects of endogenous wake-promoting orexin neuropeptides OX-A and OX-B.
LPI (LP Information)' newest research report, the “Orexin Receptor Antagonists for Insomnia Industry Forecast” looks at past sales and reviews total world Orexin Receptor Antagonists for Insomnia sales in 2022, providing a comprehensive analysis by region and market sector of projected Orexin Receptor Antagonists for Insomnia sales for 2023 through 2029. With Orexin Receptor Antagonists for Insomnia sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Orexin Receptor Antagonists for Insomnia industry.
This Insight Report provides a comprehensive analysis of the global Orexin Receptor Antagonists for Insomnia landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Orexin Receptor Antagonists for Insomnia portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Orexin Receptor Antagonists for Insomnia market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Orexin Receptor Antagonists for Insomnia and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Orexin Receptor Antagonists for Insomnia.
This report presents a comprehensive overview, market shares, and growth opportunities of Orexin Receptor Antagonists for Insomnia market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Orexin Receptor Antagonists for Insomnia market?
What factors are driving Orexin Receptor Antagonists for Insomnia market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Orexin Receptor Antagonists for Insomnia market opportunities vary by end market size?
How does Orexin Receptor Antagonists for Insomnia break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The global Orexin Receptor Antagonists for Insomnia market size is projected to grow from US$ 1076.1 million in 2022 to US$ 3354.3 million in 2029; it is expected to grow at a CAGR of 17.6% from 2023 to 2029.
United States market for Orexin Receptor Antagonists for Insomnia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Orexin Receptor Antagonists for Insomnia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Orexin Receptor Antagonists for Insomnia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Orexin Receptor Antagonists for Insomnia players cover MSD, Eisai Co., Ltd. and Idorsia, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Suvoresan is believed to play a therapeutic role in the treatment of insomnia by blocking orexin receptors and inhibiting the effects of endogenous wake-promoting orexin neuropeptides OX-A and OX-B.
LPI (LP Information)' newest research report, the “Orexin Receptor Antagonists for Insomnia Industry Forecast” looks at past sales and reviews total world Orexin Receptor Antagonists for Insomnia sales in 2022, providing a comprehensive analysis by region and market sector of projected Orexin Receptor Antagonists for Insomnia sales for 2023 through 2029. With Orexin Receptor Antagonists for Insomnia sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Orexin Receptor Antagonists for Insomnia industry.
This Insight Report provides a comprehensive analysis of the global Orexin Receptor Antagonists for Insomnia landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Orexin Receptor Antagonists for Insomnia portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Orexin Receptor Antagonists for Insomnia market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Orexin Receptor Antagonists for Insomnia and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Orexin Receptor Antagonists for Insomnia.
This report presents a comprehensive overview, market shares, and growth opportunities of Orexin Receptor Antagonists for Insomnia market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- OX1R
- OX2R
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- MSD
- Eisai Co., Ltd.
- Idorsia
What is the 10-year outlook for the global Orexin Receptor Antagonists for Insomnia market?
What factors are driving Orexin Receptor Antagonists for Insomnia market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Orexin Receptor Antagonists for Insomnia market opportunities vary by end market size?
How does Orexin Receptor Antagonists for Insomnia break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Orexin Receptor Antagonists for Insomnia Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Orexin Receptor Antagonists for Insomnia by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Orexin Receptor Antagonists for Insomnia by Country/Region, 2018, 2022 & 2029
2.2 Orexin Receptor Antagonists for Insomnia Segment by Type
2.2.1 OX1R
2.2.2 OX2R
2.3 Orexin Receptor Antagonists for Insomnia Sales by Type
2.3.1 Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
2.3.2 Global Orexin Receptor Antagonists for Insomnia Revenue and Market Share by Type (2018-2023)
2.3.3 Global Orexin Receptor Antagonists for Insomnia Sale Price by Type (2018-2023)
2.4 Orexin Receptor Antagonists for Insomnia Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Orexin Receptor Antagonists for Insomnia Sales by Application
2.5.1 Global Orexin Receptor Antagonists for Insomnia Sale Market Share by Application (2018-2023)
2.5.2 Global Orexin Receptor Antagonists for Insomnia Revenue and Market Share by Application (2018-2023)
2.5.3 Global Orexin Receptor Antagonists for Insomnia Sale Price by Application (2018-2023)
3 GLOBAL OREXIN RECEPTOR ANTAGONISTS FOR INSOMNIA BY COMPANY
3.1 Global Orexin Receptor Antagonists for Insomnia Breakdown Data by Company
3.1.1 Global Orexin Receptor Antagonists for Insomnia Annual Sales by Company (2018-2023)
3.1.2 Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Company (2018-2023)
3.2 Global Orexin Receptor Antagonists for Insomnia Annual Revenue by Company (2018-2023)
3.2.1 Global Orexin Receptor Antagonists for Insomnia Revenue by Company (2018-2023)
3.2.2 Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Company (2018-2023)
3.3 Global Orexin Receptor Antagonists for Insomnia Sale Price by Company
3.4 Key Manufacturers Orexin Receptor Antagonists for Insomnia Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Orexin Receptor Antagonists for Insomnia Product Location Distribution
3.4.2 Players Orexin Receptor Antagonists for Insomnia Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OREXIN RECEPTOR ANTAGONISTS FOR INSOMNIA BY GEOGRAPHIC REGION
4.1 World Historic Orexin Receptor Antagonists for Insomnia Market Size by Geographic Region (2018-2023)
4.1.1 Global Orexin Receptor Antagonists for Insomnia Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Orexin Receptor Antagonists for Insomnia Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Orexin Receptor Antagonists for Insomnia Market Size by Country/Region (2018-2023)
4.2.1 Global Orexin Receptor Antagonists for Insomnia Annual Sales by Country/Region (2018-2023)
4.2.2 Global Orexin Receptor Antagonists for Insomnia Annual Revenue by Country/Region (2018-2023)
4.3 Americas Orexin Receptor Antagonists for Insomnia Sales Growth
4.4 APAC Orexin Receptor Antagonists for Insomnia Sales Growth
4.5 Europe Orexin Receptor Antagonists for Insomnia Sales Growth
4.6 Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Growth
5 AMERICAS
5.1 Americas Orexin Receptor Antagonists for Insomnia Sales by Country
5.1.1 Americas Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023)
5.1.2 Americas Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023)
5.2 Americas Orexin Receptor Antagonists for Insomnia Sales by Type
5.3 Americas Orexin Receptor Antagonists for Insomnia Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Orexin Receptor Antagonists for Insomnia Sales by Region
6.1.1 APAC Orexin Receptor Antagonists for Insomnia Sales by Region (2018-2023)
6.1.2 APAC Orexin Receptor Antagonists for Insomnia Revenue by Region (2018-2023)
6.2 APAC Orexin Receptor Antagonists for Insomnia Sales by Type
6.3 APAC Orexin Receptor Antagonists for Insomnia Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Orexin Receptor Antagonists for Insomnia by Country
7.1.1 Europe Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023)
7.1.2 Europe Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023)
7.2 Europe Orexin Receptor Antagonists for Insomnia Sales by Type
7.3 Europe Orexin Receptor Antagonists for Insomnia Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Orexin Receptor Antagonists for Insomnia by Country
8.1.1 Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023)
8.1.2 Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023)
8.2 Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Type
8.3 Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Orexin Receptor Antagonists for Insomnia
10.3 Manufacturing Process Analysis of Orexin Receptor Antagonists for Insomnia
10.4 Industry Chain Structure of Orexin Receptor Antagonists for Insomnia
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Orexin Receptor Antagonists for Insomnia Distributors
11.3 Orexin Receptor Antagonists for Insomnia Customer
12 WORLD FORECAST REVIEW FOR OREXIN RECEPTOR ANTAGONISTS FOR INSOMNIA BY GEOGRAPHIC REGION
12.1 Global Orexin Receptor Antagonists for Insomnia Market Size Forecast by Region
12.1.1 Global Orexin Receptor Antagonists for Insomnia Forecast by Region (2024-2029)
12.1.2 Global Orexin Receptor Antagonists for Insomnia Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Orexin Receptor Antagonists for Insomnia Forecast by Type
12.7 Global Orexin Receptor Antagonists for Insomnia Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 MSD
13.1.1 MSD Company Information
13.1.2 MSD Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
13.1.3 MSD Orexin Receptor Antagonists for Insomnia Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 MSD Main Business Overview
13.1.5 MSD Latest Developments
13.2 Eisai Co., Ltd.
13.2.1 Eisai Co., Ltd. Company Information
13.2.2 Eisai Co., Ltd. Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
13.2.3 Eisai Co., Ltd. Orexin Receptor Antagonists for Insomnia Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Eisai Co., Ltd. Main Business Overview
13.2.5 Eisai Co., Ltd. Latest Developments
13.3 Idorsia
13.3.1 Idorsia Company Information
13.3.2 Idorsia Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
13.3.3 Idorsia Orexin Receptor Antagonists for Insomnia Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Idorsia Main Business Overview
13.3.5 Idorsia Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Orexin Receptor Antagonists for Insomnia Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Orexin Receptor Antagonists for Insomnia by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Orexin Receptor Antagonists for Insomnia by Country/Region, 2018, 2022 & 2029
2.2 Orexin Receptor Antagonists for Insomnia Segment by Type
2.2.1 OX1R
2.2.2 OX2R
2.3 Orexin Receptor Antagonists for Insomnia Sales by Type
2.3.1 Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
2.3.2 Global Orexin Receptor Antagonists for Insomnia Revenue and Market Share by Type (2018-2023)
2.3.3 Global Orexin Receptor Antagonists for Insomnia Sale Price by Type (2018-2023)
2.4 Orexin Receptor Antagonists for Insomnia Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Orexin Receptor Antagonists for Insomnia Sales by Application
2.5.1 Global Orexin Receptor Antagonists for Insomnia Sale Market Share by Application (2018-2023)
2.5.2 Global Orexin Receptor Antagonists for Insomnia Revenue and Market Share by Application (2018-2023)
2.5.3 Global Orexin Receptor Antagonists for Insomnia Sale Price by Application (2018-2023)
3 GLOBAL OREXIN RECEPTOR ANTAGONISTS FOR INSOMNIA BY COMPANY
3.1 Global Orexin Receptor Antagonists for Insomnia Breakdown Data by Company
3.1.1 Global Orexin Receptor Antagonists for Insomnia Annual Sales by Company (2018-2023)
3.1.2 Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Company (2018-2023)
3.2 Global Orexin Receptor Antagonists for Insomnia Annual Revenue by Company (2018-2023)
3.2.1 Global Orexin Receptor Antagonists for Insomnia Revenue by Company (2018-2023)
3.2.2 Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Company (2018-2023)
3.3 Global Orexin Receptor Antagonists for Insomnia Sale Price by Company
3.4 Key Manufacturers Orexin Receptor Antagonists for Insomnia Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Orexin Receptor Antagonists for Insomnia Product Location Distribution
3.4.2 Players Orexin Receptor Antagonists for Insomnia Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OREXIN RECEPTOR ANTAGONISTS FOR INSOMNIA BY GEOGRAPHIC REGION
4.1 World Historic Orexin Receptor Antagonists for Insomnia Market Size by Geographic Region (2018-2023)
4.1.1 Global Orexin Receptor Antagonists for Insomnia Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Orexin Receptor Antagonists for Insomnia Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Orexin Receptor Antagonists for Insomnia Market Size by Country/Region (2018-2023)
4.2.1 Global Orexin Receptor Antagonists for Insomnia Annual Sales by Country/Region (2018-2023)
4.2.2 Global Orexin Receptor Antagonists for Insomnia Annual Revenue by Country/Region (2018-2023)
4.3 Americas Orexin Receptor Antagonists for Insomnia Sales Growth
4.4 APAC Orexin Receptor Antagonists for Insomnia Sales Growth
4.5 Europe Orexin Receptor Antagonists for Insomnia Sales Growth
4.6 Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Growth
5 AMERICAS
5.1 Americas Orexin Receptor Antagonists for Insomnia Sales by Country
5.1.1 Americas Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023)
5.1.2 Americas Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023)
5.2 Americas Orexin Receptor Antagonists for Insomnia Sales by Type
5.3 Americas Orexin Receptor Antagonists for Insomnia Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Orexin Receptor Antagonists for Insomnia Sales by Region
6.1.1 APAC Orexin Receptor Antagonists for Insomnia Sales by Region (2018-2023)
6.1.2 APAC Orexin Receptor Antagonists for Insomnia Revenue by Region (2018-2023)
6.2 APAC Orexin Receptor Antagonists for Insomnia Sales by Type
6.3 APAC Orexin Receptor Antagonists for Insomnia Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Orexin Receptor Antagonists for Insomnia by Country
7.1.1 Europe Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023)
7.1.2 Europe Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023)
7.2 Europe Orexin Receptor Antagonists for Insomnia Sales by Type
7.3 Europe Orexin Receptor Antagonists for Insomnia Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Orexin Receptor Antagonists for Insomnia by Country
8.1.1 Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023)
8.1.2 Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023)
8.2 Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Type
8.3 Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Orexin Receptor Antagonists for Insomnia
10.3 Manufacturing Process Analysis of Orexin Receptor Antagonists for Insomnia
10.4 Industry Chain Structure of Orexin Receptor Antagonists for Insomnia
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Orexin Receptor Antagonists for Insomnia Distributors
11.3 Orexin Receptor Antagonists for Insomnia Customer
12 WORLD FORECAST REVIEW FOR OREXIN RECEPTOR ANTAGONISTS FOR INSOMNIA BY GEOGRAPHIC REGION
12.1 Global Orexin Receptor Antagonists for Insomnia Market Size Forecast by Region
12.1.1 Global Orexin Receptor Antagonists for Insomnia Forecast by Region (2024-2029)
12.1.2 Global Orexin Receptor Antagonists for Insomnia Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Orexin Receptor Antagonists for Insomnia Forecast by Type
12.7 Global Orexin Receptor Antagonists for Insomnia Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 MSD
13.1.1 MSD Company Information
13.1.2 MSD Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
13.1.3 MSD Orexin Receptor Antagonists for Insomnia Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 MSD Main Business Overview
13.1.5 MSD Latest Developments
13.2 Eisai Co., Ltd.
13.2.1 Eisai Co., Ltd. Company Information
13.2.2 Eisai Co., Ltd. Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
13.2.3 Eisai Co., Ltd. Orexin Receptor Antagonists for Insomnia Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Eisai Co., Ltd. Main Business Overview
13.2.5 Eisai Co., Ltd. Latest Developments
13.3 Idorsia
13.3.1 Idorsia Company Information
13.3.2 Idorsia Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
13.3.3 Idorsia Orexin Receptor Antagonists for Insomnia Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Idorsia Main Business Overview
13.3.5 Idorsia Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Orexin Receptor Antagonists for Insomnia Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Orexin Receptor Antagonists for Insomnia Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of OX1R
Table 4. Major Players of OX2R
Table 5. Global Orexin Receptor Antagonists for Insomnia Sales by Type (2018-2023) & (K Units)
Table 6. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
Table 7. Global Orexin Receptor Antagonists for Insomnia Revenue by Type (2018-2023) & ($ million)
Table 8. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Type (2018-2023)
Table 9. Global Orexin Receptor Antagonists for Insomnia Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Orexin Receptor Antagonists for Insomnia Sales by Application (2018-2023) & (K Units)
Table 11. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2018-2023)
Table 12. Global Orexin Receptor Antagonists for Insomnia Revenue by Application (2018-2023)
Table 13. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Application (2018-2023)
Table 14. Global Orexin Receptor Antagonists for Insomnia Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Orexin Receptor Antagonists for Insomnia Sales by Company (2018-2023) & (K Units)
Table 16. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Company (2018-2023)
Table 17. Global Orexin Receptor Antagonists for Insomnia Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Company (2018-2023)
Table 19. Global Orexin Receptor Antagonists for Insomnia Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Orexin Receptor Antagonists for Insomnia Producing Area Distribution and Sales Area
Table 21. Players Orexin Receptor Antagonists for Insomnia Products Offered
Table 22. Orexin Receptor Antagonists for Insomnia Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Orexin Receptor Antagonists for Insomnia Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Orexin Receptor Antagonists for Insomnia Sales Market Share Geographic Region (2018-2023)
Table 27. Global Orexin Receptor Antagonists for Insomnia Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Orexin Receptor Antagonists for Insomnia Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Country/Region (2018-2023)
Table 31. Global Orexin Receptor Antagonists for Insomnia Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023) & (K Units)
Table 34. Americas Orexin Receptor Antagonists for Insomnia Sales Market Share by Country (2018-2023)
Table 35. Americas Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country (2018-2023)
Table 37. Americas Orexin Receptor Antagonists for Insomnia Sales by Type (2018-2023) & (K Units)
Table 38. Americas Orexin Receptor Antagonists for Insomnia Sales by Application (2018-2023) & (K Units)
Table 39. APAC Orexin Receptor Antagonists for Insomnia Sales by Region (2018-2023) & (K Units)
Table 40. APAC Orexin Receptor Antagonists for Insomnia Sales Market Share by Region (2018-2023)
Table 41. APAC Orexin Receptor Antagonists for Insomnia Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Orexin Receptor Antagonists for Insomnia Revenue Market Share by Region (2018-2023)
Table 43. APAC Orexin Receptor Antagonists for Insomnia Sales by Type (2018-2023) & (K Units)
Table 44. APAC Orexin Receptor Antagonists for Insomnia Sales by Application (2018-2023) & (K Units)
Table 45. Europe Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023) & (K Units)
Table 46. Europe Orexin Receptor Antagonists for Insomnia Sales Market Share by Country (2018-2023)
Table 47. Europe Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country (2018-2023)
Table 49. Europe Orexin Receptor Antagonists for Insomnia Sales by Type (2018-2023) & (K Units)
Table 50. Europe Orexin Receptor Antagonists for Insomnia Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Orexin Receptor Antagonists for Insomnia
Table 58. Key Market Challenges & Risks of Orexin Receptor Antagonists for Insomnia
Table 59. Key Industry Trends of Orexin Receptor Antagonists for Insomnia
Table 60. Orexin Receptor Antagonists for Insomnia Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Orexin Receptor Antagonists for Insomnia Distributors List
Table 63. Orexin Receptor Antagonists for Insomnia Customer List
Table 64. Global Orexin Receptor Antagonists for Insomnia Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Orexin Receptor Antagonists for Insomnia Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Orexin Receptor Antagonists for Insomnia Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Orexin Receptor Antagonists for Insomnia Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Orexin Receptor Antagonists for Insomnia Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Orexin Receptor Antagonists for Insomnia Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Orexin Receptor Antagonists for Insomnia Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Orexin Receptor Antagonists for Insomnia Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Orexin Receptor Antagonists for Insomnia Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Orexin Receptor Antagonists for Insomnia Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Orexin Receptor Antagonists for Insomnia Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Orexin Receptor Antagonists for Insomnia Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. MSD Basic Information, Orexin Receptor Antagonists for Insomnia Manufacturing Base, Sales Area and Its Competitors
Table 79. MSD Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
Table 80. MSD Orexin Receptor Antagonists for Insomnia Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. MSD Main Business
Table 82. MSD Latest Developments
Table 83. Eisai Co., Ltd. Basic Information, Orexin Receptor Antagonists for Insomnia Manufacturing Base, Sales Area and Its Competitors
Table 84. Eisai Co., Ltd. Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
Table 85. Eisai Co., Ltd. Orexin Receptor Antagonists for Insomnia Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Eisai Co., Ltd. Main Business
Table 87. Eisai Co., Ltd. Latest Developments
Table 88. Idorsia Basic Information, Orexin Receptor Antagonists for Insomnia Manufacturing Base, Sales Area and Its Competitors
Table 89. Idorsia Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
Table 90. Idorsia Orexin Receptor Antagonists for Insomnia Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Idorsia Main Business
Table 92. Idorsia Latest Developments
Table 1. Orexin Receptor Antagonists for Insomnia Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Orexin Receptor Antagonists for Insomnia Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of OX1R
Table 4. Major Players of OX2R
Table 5. Global Orexin Receptor Antagonists for Insomnia Sales by Type (2018-2023) & (K Units)
Table 6. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
Table 7. Global Orexin Receptor Antagonists for Insomnia Revenue by Type (2018-2023) & ($ million)
Table 8. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Type (2018-2023)
Table 9. Global Orexin Receptor Antagonists for Insomnia Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Orexin Receptor Antagonists for Insomnia Sales by Application (2018-2023) & (K Units)
Table 11. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2018-2023)
Table 12. Global Orexin Receptor Antagonists for Insomnia Revenue by Application (2018-2023)
Table 13. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Application (2018-2023)
Table 14. Global Orexin Receptor Antagonists for Insomnia Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Orexin Receptor Antagonists for Insomnia Sales by Company (2018-2023) & (K Units)
Table 16. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Company (2018-2023)
Table 17. Global Orexin Receptor Antagonists for Insomnia Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Company (2018-2023)
Table 19. Global Orexin Receptor Antagonists for Insomnia Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Orexin Receptor Antagonists for Insomnia Producing Area Distribution and Sales Area
Table 21. Players Orexin Receptor Antagonists for Insomnia Products Offered
Table 22. Orexin Receptor Antagonists for Insomnia Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Orexin Receptor Antagonists for Insomnia Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Orexin Receptor Antagonists for Insomnia Sales Market Share Geographic Region (2018-2023)
Table 27. Global Orexin Receptor Antagonists for Insomnia Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Orexin Receptor Antagonists for Insomnia Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Country/Region (2018-2023)
Table 31. Global Orexin Receptor Antagonists for Insomnia Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023) & (K Units)
Table 34. Americas Orexin Receptor Antagonists for Insomnia Sales Market Share by Country (2018-2023)
Table 35. Americas Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country (2018-2023)
Table 37. Americas Orexin Receptor Antagonists for Insomnia Sales by Type (2018-2023) & (K Units)
Table 38. Americas Orexin Receptor Antagonists for Insomnia Sales by Application (2018-2023) & (K Units)
Table 39. APAC Orexin Receptor Antagonists for Insomnia Sales by Region (2018-2023) & (K Units)
Table 40. APAC Orexin Receptor Antagonists for Insomnia Sales Market Share by Region (2018-2023)
Table 41. APAC Orexin Receptor Antagonists for Insomnia Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Orexin Receptor Antagonists for Insomnia Revenue Market Share by Region (2018-2023)
Table 43. APAC Orexin Receptor Antagonists for Insomnia Sales by Type (2018-2023) & (K Units)
Table 44. APAC Orexin Receptor Antagonists for Insomnia Sales by Application (2018-2023) & (K Units)
Table 45. Europe Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023) & (K Units)
Table 46. Europe Orexin Receptor Antagonists for Insomnia Sales Market Share by Country (2018-2023)
Table 47. Europe Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country (2018-2023)
Table 49. Europe Orexin Receptor Antagonists for Insomnia Sales by Type (2018-2023) & (K Units)
Table 50. Europe Orexin Receptor Antagonists for Insomnia Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Orexin Receptor Antagonists for Insomnia
Table 58. Key Market Challenges & Risks of Orexin Receptor Antagonists for Insomnia
Table 59. Key Industry Trends of Orexin Receptor Antagonists for Insomnia
Table 60. Orexin Receptor Antagonists for Insomnia Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Orexin Receptor Antagonists for Insomnia Distributors List
Table 63. Orexin Receptor Antagonists for Insomnia Customer List
Table 64. Global Orexin Receptor Antagonists for Insomnia Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Orexin Receptor Antagonists for Insomnia Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Orexin Receptor Antagonists for Insomnia Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Orexin Receptor Antagonists for Insomnia Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Orexin Receptor Antagonists for Insomnia Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Orexin Receptor Antagonists for Insomnia Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Orexin Receptor Antagonists for Insomnia Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Orexin Receptor Antagonists for Insomnia Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Orexin Receptor Antagonists for Insomnia Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Orexin Receptor Antagonists for Insomnia Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Orexin Receptor Antagonists for Insomnia Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Orexin Receptor Antagonists for Insomnia Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. MSD Basic Information, Orexin Receptor Antagonists for Insomnia Manufacturing Base, Sales Area and Its Competitors
Table 79. MSD Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
Table 80. MSD Orexin Receptor Antagonists for Insomnia Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. MSD Main Business
Table 82. MSD Latest Developments
Table 83. Eisai Co., Ltd. Basic Information, Orexin Receptor Antagonists for Insomnia Manufacturing Base, Sales Area and Its Competitors
Table 84. Eisai Co., Ltd. Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
Table 85. Eisai Co., Ltd. Orexin Receptor Antagonists for Insomnia Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Eisai Co., Ltd. Main Business
Table 87. Eisai Co., Ltd. Latest Developments
Table 88. Idorsia Basic Information, Orexin Receptor Antagonists for Insomnia Manufacturing Base, Sales Area and Its Competitors
Table 89. Idorsia Orexin Receptor Antagonists for Insomnia Product Portfolios and Specifications
Table 90. Idorsia Orexin Receptor Antagonists for Insomnia Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Idorsia Main Business
Table 92. Idorsia Latest Developments
LIST OF FIGURES
Figure 1. Picture of Orexin Receptor Antagonists for Insomnia
Figure 2. Orexin Receptor Antagonists for Insomnia Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Orexin Receptor Antagonists for Insomnia Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Orexin Receptor Antagonists for Insomnia Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Orexin Receptor Antagonists for Insomnia Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of OX1R
Figure 10. Product Picture of OX2R
Figure 11. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Type in 2022
Figure 12. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Type (2018-2023)
Figure 13. Orexin Receptor Antagonists for Insomnia Consumed in Hospital
Figure 14. Global Orexin Receptor Antagonists for Insomnia Market: Hospital (2018-2023) & (K Units)
Figure 15. Orexin Receptor Antagonists for Insomnia Consumed in Clinic
Figure 16. Global Orexin Receptor Antagonists for Insomnia Market: Clinic (2018-2023) & (K Units)
Figure 17. Orexin Receptor Antagonists for Insomnia Consumed in Other
Figure 18. Global Orexin Receptor Antagonists for Insomnia Market: Other (2018-2023) & (K Units)
Figure 19. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2022)
Figure 20. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Application in 2022
Figure 21. Orexin Receptor Antagonists for Insomnia Sales Market by Company in 2022 (K Units)
Figure 22. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Company in 2022
Figure 23. Orexin Receptor Antagonists for Insomnia Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Company in 2022
Figure 25. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Orexin Receptor Antagonists for Insomnia Sales 2018-2023 (K Units)
Figure 28. Americas Orexin Receptor Antagonists for Insomnia Revenue 2018-2023 ($ Millions)
Figure 29. APAC Orexin Receptor Antagonists for Insomnia Sales 2018-2023 (K Units)
Figure 30. APAC Orexin Receptor Antagonists for Insomnia Revenue 2018-2023 ($ Millions)
Figure 31. Europe Orexin Receptor Antagonists for Insomnia Sales 2018-2023 (K Units)
Figure 32. Europe Orexin Receptor Antagonists for Insomnia Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue 2018-2023 ($ Millions)
Figure 35. Americas Orexin Receptor Antagonists for Insomnia Sales Market Share by Country in 2022
Figure 36. Americas Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country in 2022
Figure 37. Americas Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
Figure 38. Americas Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2018-2023)
Figure 39. United States Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Orexin Receptor Antagonists for Insomnia Sales Market Share by Region in 2022
Figure 44. APAC Orexin Receptor Antagonists for Insomnia Revenue Market Share by Regions in 2022
Figure 45. APAC Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
Figure 46. APAC Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2018-2023)
Figure 47. China Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Orexin Receptor Antagonists for Insomnia Sales Market Share by Country in 2022
Figure 55. Europe Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country in 2022
Figure 56. Europe Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
Figure 57. Europe Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2018-2023)
Figure 58. Germany Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2018-2023)
Figure 67. Egypt Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Orexin Receptor Antagonists for Insomnia in 2022
Figure 73. Manufacturing Process Analysis of Orexin Receptor Antagonists for Insomnia
Figure 74. Industry Chain Structure of Orexin Receptor Antagonists for Insomnia
Figure 75. Channels of Distribution
Figure 76. Global Orexin Receptor Antagonists for Insomnia Sales Market Forecast by Region (2024-2029)
Figure 77. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Orexin Receptor Antagonists for Insomnia Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Orexin Receptor Antagonists for Insomnia Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Orexin Receptor Antagonists for Insomnia
Figure 2. Orexin Receptor Antagonists for Insomnia Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Orexin Receptor Antagonists for Insomnia Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Orexin Receptor Antagonists for Insomnia Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Orexin Receptor Antagonists for Insomnia Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of OX1R
Figure 10. Product Picture of OX2R
Figure 11. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Type in 2022
Figure 12. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Type (2018-2023)
Figure 13. Orexin Receptor Antagonists for Insomnia Consumed in Hospital
Figure 14. Global Orexin Receptor Antagonists for Insomnia Market: Hospital (2018-2023) & (K Units)
Figure 15. Orexin Receptor Antagonists for Insomnia Consumed in Clinic
Figure 16. Global Orexin Receptor Antagonists for Insomnia Market: Clinic (2018-2023) & (K Units)
Figure 17. Orexin Receptor Antagonists for Insomnia Consumed in Other
Figure 18. Global Orexin Receptor Antagonists for Insomnia Market: Other (2018-2023) & (K Units)
Figure 19. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2022)
Figure 20. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Application in 2022
Figure 21. Orexin Receptor Antagonists for Insomnia Sales Market by Company in 2022 (K Units)
Figure 22. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Company in 2022
Figure 23. Orexin Receptor Antagonists for Insomnia Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Company in 2022
Figure 25. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Orexin Receptor Antagonists for Insomnia Sales 2018-2023 (K Units)
Figure 28. Americas Orexin Receptor Antagonists for Insomnia Revenue 2018-2023 ($ Millions)
Figure 29. APAC Orexin Receptor Antagonists for Insomnia Sales 2018-2023 (K Units)
Figure 30. APAC Orexin Receptor Antagonists for Insomnia Revenue 2018-2023 ($ Millions)
Figure 31. Europe Orexin Receptor Antagonists for Insomnia Sales 2018-2023 (K Units)
Figure 32. Europe Orexin Receptor Antagonists for Insomnia Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue 2018-2023 ($ Millions)
Figure 35. Americas Orexin Receptor Antagonists for Insomnia Sales Market Share by Country in 2022
Figure 36. Americas Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country in 2022
Figure 37. Americas Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
Figure 38. Americas Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2018-2023)
Figure 39. United States Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Orexin Receptor Antagonists for Insomnia Sales Market Share by Region in 2022
Figure 44. APAC Orexin Receptor Antagonists for Insomnia Revenue Market Share by Regions in 2022
Figure 45. APAC Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
Figure 46. APAC Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2018-2023)
Figure 47. China Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Orexin Receptor Antagonists for Insomnia Sales Market Share by Country in 2022
Figure 55. Europe Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country in 2022
Figure 56. Europe Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
Figure 57. Europe Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2018-2023)
Figure 58. Germany Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Orexin Receptor Antagonists for Insomnia Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2018-2023)
Figure 67. Egypt Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Orexin Receptor Antagonists for Insomnia Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Orexin Receptor Antagonists for Insomnia in 2022
Figure 73. Manufacturing Process Analysis of Orexin Receptor Antagonists for Insomnia
Figure 74. Industry Chain Structure of Orexin Receptor Antagonists for Insomnia
Figure 75. Channels of Distribution
Figure 76. Global Orexin Receptor Antagonists for Insomnia Sales Market Forecast by Region (2024-2029)
Figure 77. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Orexin Receptor Antagonists for Insomnia Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Orexin Receptor Antagonists for Insomnia Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share Forecast by Application (2024-2029)
